Search

everythinglearnresearchcommunity

for

Search:↓

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

The p53 protein helps control hair follicle shrinking by promoting cell death in mice.

miR-22, a type of microRNA, controls hair growth and its overproduction can cause hair loss, while its absence can speed up hair growth.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Men are more likely to have larger basal cell carcinomas and squamous cell carcinomas, while women have more superficial basal cell carcinomas and tumors on their legs and central face.

The dog's skin condition improved after removing a tumor that was causing hormone imbalances.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Model improves accuracy in predicting hair loss effects.

Ozone therapy might improve cancer treatment and reduce its side effects.

An automated system can predict death risk in thin melanoma by analyzing immune cells.

Basaloid follicular hamartoma's appearance can be similar to other skin conditions, and diagnosis should consider both the look and behavior of the tumor.

The environment around the time of conception can change the VTRNA2-1 gene in a way that lasts for years and may affect disease risk.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

Some steroid-induced health issues in rodents improved after stopping treatment, but hair loss and eye problems did not.

The transition from growth to regression in Cashmere goat hair follicles involves changes in expression of genes related to keratin and cell differentiation.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

A pineal tumor caused a boy's early puberty, which changed from peripheral to central after treatment.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Meis1 is crucial for skin health and tumor development.

Hair follicle regeneration may slow tumor growth.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.